112 related articles for article (PubMed ID: 38411346)
1. Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway.
Guo H; Wang Z; Yin K; Ma R; Zhang Y; Yin F; Li H; Yin D
Mol Carcinog; 2024 Apr; 63(4):701-713. PubMed ID: 38411346
[TBL] [Abstract][Full Text] [Related]
2. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
3. Role of Sciellin in gallbladder cancer proliferation and formation of neutrophil extracellular traps.
Li Y; Yuan R; Ren T; Yang B; Miao H; Liu L; Li Y; Cai C; Yang Y; Hu Y; Jiang C; Xu Q; Zhang Y; Liu Y
Cell Death Dis; 2021 Jan; 12(1):30. PubMed ID: 33414368
[TBL] [Abstract][Full Text] [Related]
4. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
[TBL] [Abstract][Full Text] [Related]
5. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract][Full Text] [Related]
6. LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling.
Gao F; Chen J; Zhang T; Liu N
Exp Cell Res; 2022 Dec; 421(1):113360. PubMed ID: 36122769
[TBL] [Abstract][Full Text] [Related]
7. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
[TBL] [Abstract][Full Text] [Related]
8. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
[TBL] [Abstract][Full Text] [Related]
9. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
[TBL] [Abstract][Full Text] [Related]
10.
Li Y; Wei J; Sun Y; Zhou W; Ma X; Guo J; Zhang H; Jin T
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958803
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
13. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
14. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
[TBL] [Abstract][Full Text] [Related]
15. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial-mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma.
Yang M; Yao P; Lang X; Li X; Zhang D
Bioengineered; 2021 Dec; 12(2):12800-12811. PubMed ID: 34895038
[TBL] [Abstract][Full Text] [Related]
16. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.
Wang ZL; Wang C; Liu W; Ai ZL
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693087
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of long non-coding RNA HOTAIR promotes angiogenesis via regulating miR-126/SCEL pathways in burn wound healing.
Jiang B; Tang Y; Wang H; Chen C; Yu W; Sun H; Duan M; Lin X; Liang P
Cell Death Dis; 2020 Jan; 11(1):61. PubMed ID: 31974341
[TBL] [Abstract][Full Text] [Related]
18. Urantide alleviates the symptoms of atherosclerotic rats in vivo and in vitro models through the JAK2/STAT3 signaling pathway.
Wang T; Xie L; Bi H; Li Y; Li Y; Zhao J
Eur J Pharmacol; 2021 Jul; 902():174037. PubMed ID: 33891969
[TBL] [Abstract][Full Text] [Related]
19. Phlorizin from sweet tea inhibits the progress of esophageal cancer by antagonizing the JAK2/STAT3 signaling pathway.
Jia Z; Xie Y; Wu H; Wang Z; Li A; Li Z; Yang Z; Zhang Z; Xing Z; Zhang X
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036398
[TBL] [Abstract][Full Text] [Related]
20. SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma.
Wang M; Sun X; Xin H; Wen Z; Cheng Y
Cancer Med; 2022 Dec; 11(23):4526-4543. PubMed ID: 35593388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
